| Offering Information |
| Expected Date | - |
| Proposed Exchange/Ticker |
Nasdaq: ABPI |
| Security Type |
Common Stock |
| Lead Underwriter |
Jefferies & Co Inc |
| Days In Registration |
258 |
| Date Filed |
11-Feb-2005 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2008) |
| Industry |
Manufacturing |
| Business Description |
Accentia Biopharmaceuticals, located in Tampa, Florida, is a biotechnology company engaged in the development of active medical indgredients for respiratory diseases and oncology. The company was incorporated in 2002. |
| Revenue |
$27.5M |
| Net Income |
-$35.4M |
| Shares Outstanding (post-offering) |
28.87M |
| Contact |
- |
| Number of Employees |
- |
|
| Original Filing Information |
| US |
| Shares Filed |
6.25M |
| Secondary Shares Filed | 1.0M |
| · As a Percent |
16.0 |
| Primary Shares Filed |
5.25M |
| · As a Percent |
84.0 |
| Overallotment Shares Filed |
360.0K |
| File Amount |
$75.0M |
| File Price Range |
$13.00 - $11.00 |
| File Mid Price |
$12.00 |
Current Filing Information
(Amended 3-Oct-2005) |
|
US |
|
Shares Filed |
2.5M |
| Secondary Shares Filed |
- |
| · As a Percent |
- |
| Primary Shares Filed |
2.5M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
- |
| File Amount |
$22.5M |
| · % Change from Original |
-70.0 |
| File Price Range |
$10.00 - $8.00 |
| File Mid Price |
$9.00 |
|
